Lipoxygenase directed anti-inflammatory and anti-cancerous secondary metabolites: ADMET-based screening, molecular docking and dynamics simulation

References

• Accelrys Software Inc. 2013. Discovery studio modeling environment ( Release 3.1). San Diego, CA: Author.
   Google Scholar
• Altavilla, D., Squadrito, F., Bitto, A., Polito, F., Burnett, B. P., Di Stefano, V., & Minutoli, L. (2009). Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. British Journal of Pharmacology, 157, 1410–1418.10.1111/bph.2009.157.issue-8
   PubMed Web of Science ®Google Scholar
• Avis, I., Hong, S. H., Martinez, A., Moody, T., Choi, Y. H., Trepel, J., … Mulshine, J. L. (2001). Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. Federation of American Societies for Experimental Biology Journal, 15, 2007–2009.
   PubMed Web of Science ®Google Scholar
• Balani, S. K., Miwa, G. T., Gan, L. S., Wu, J. T., & Lee, F. W. (2005). Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. Current Topics in Medicinal Chemistry, 5, 1033–1038.10.2174/156802605774297038
   PubMed Web of Science ®Google Scholar
• Berger, W., De Chandt, M. T., & Cairns, C. B. (2007). Zileuton: Clinical implications of 5-lipoxygenase inhibition in severe airway disease. International Journal of Clinical Practice, 61, 663–676.10.1111/ijcp.2007.61.issue-4
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., … Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28, 235–242.10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Catalano, A., & Procopio, A. (2005). New aspects on the role of lipoxygenases in cancer progression. Journal of Histology Histopathology, 20, 969–975.
   PubMed Web of Science ®Google Scholar
• Chen, X., Sood, S., Yang, C. S., Li, N., & Sun, Z. (2006). Five-lipoxygenase pathway of arachidonic acid metabolism in carcinogenesis and cancer chemoprevention. Current Cancer Drug Targets, 6, 613–622.10.2174/156800906778742451
   PubMed Web of Science ®Google Scholar
• Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860–867.10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43, 3867–3877.10.1021/jm000292e
   PubMed Web of Science ®Google Scholar
• Eren, G., Macchiarulo, A., & Banoglu, E. (2012). From molecular docking to 3D-quantitative structure-activity relationships (3D-QSAR): Insights into the binding mode of 5-lipoxygenase inhibitors. Molecular Informatics, 31, 123–134.10.1002/minf.v31.2
   PubMed Web of Science ®Google Scholar
• Gilbert, N. C., Bartlett, S. G., Waight, M. T., Neau, D. B., Boeglin, W. E., Brash, A. R., & Newcomer, M. E. (2011). The structure of human 5-lipoxygenase. Science, 331, 217–219.10.1126/science.1197203
   PubMed Web of Science ®Google Scholar
• Gonçalves, A. S., França, T. C. C., Figueroa-Villar, J. D., & Pascutti, P. G. (2011). Molecular dynamics simulations and QM/MM studies of the reactivation by 2-PAM of tabun inhibited human acethylcolinesterase. Journal of the Brazilian Chemical Society, 22, 155–165.10.1590/S0103-50532011000100021
   Web of Science ®Google Scholar
• Gregor, J. I., Kilian, M., Heukamp, I., Kiewert, C., Kristiansen, G., Schimke, I., … Wenger, F. A. (2005). Effects of selective COX-2 and 5-LOX inhibition on prostaglandin and leukotriene synthesis in ductal pancreatic cancer in Syrian hamster. Prostaglandins, Leukotrienes and Essential Fatty Acids, 73, 89–97.10.1016/j.plefa.2005.04.016
   PubMed Web of Science ®Google Scholar
• Guo, C., & Nie, D. (2012). Are lipoxygenases valid targets of cancer prevention and treatment? Journal of Carcinogenesis and Mutagenesis, 4172, 2157–2518.
   Google Scholar
• Haeggström, J. Z., & Funk, C. D. (2011). Lipoxygenase and leukotriene pathways: Biochemistry, biology, and roles in disease. Chemical Reviews, 111, 5866–5898.10.1021/cr200246d
   PubMed Web of Science ®Google Scholar
• Hennig, R., Ding, X. Z., & Adrian, T. E. (2004). On the role of the islets of Langerhans in pancreatic cancer. Journal of Histology Histopathology, 19, 999–1011.
   PubMed Web of Science ®Google Scholar
• Hong, S. H., Avis, I., Vos, M. D., Martinez, A., Treston, A. M., & Mulshine, J. L. (1999). Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Research, 59, 2223–2228.
   PubMed Web of Science ®Google Scholar
• Hop, C. E., Cole, M. J., Davidson, R. E., Duignan, D. B., Federico, J., Janiszewski, J., … Zhao, S. X. (2008). High throughput ADME screening: Practical considerations, impact on the portfolio and enabler of in silico ADME models. Current Drug Metabolism, 9, 847–853.10.2174/138920008786485092
   PubMed Web of Science ®Google Scholar
• Hou, T. J., & Xu, X. J. (2004). Recent development and application of virtual screening in drug discovery: An overview. Current Pharmaceutical Design, 10, 1011–1033.10.2174/1381612043452721
   PubMed Web of Science ®Google Scholar
• Ivanov, I., Heydeck, D., Hofheinz, K., Roffeis, J., O’Donnell, V. B., Kuhn, H., & Walther, M. (2010). Molecular enzymology of lipoxygenases. Archives of Biochemistry and Biophysics, 503, 161–174.10.1016/j.abb.2010.08.016
   PubMed Web of Science ®Google Scholar
• Jawien, J., & Korbut, R. (2010). The current view on the role of leukotrienes in atherogenesis. Journal of Physiology Pharmacology, 61, 647–650.
   PubMed Web of Science ®Google Scholar
• Kang, J., Xie, C., Li, Z., Nagarajan, S., Schauss, A. G., Wu, T., & Wu, X. (2011). Flavonoids from acai (Euterpe oleracea Mart.) pulp and their antioxidant and anti-inflammatory activities. Food Chemistry, 128, 152–157.10.1016/j.foodchem.2011.03.011
   PubMed Web of Science ®Google Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., … Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33, 889–897.10.1021/ar000033j
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., Open Source Drug Discovery Consortium, & Lynn, A (2014). g_mmpbsa – A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54, 1951–1962.10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Kumar, N. D. R., George, C. V., Suresh, P. K., & Kumar, A. R. (2012). Cytotoxicity, apoptosis induction and anti-metastatic potential of oroxylum indicum in human breast cancer cells. Asian Pacific Journal of Cancer Prevention, 13, 2729–2734.10.7314/APJCP.2012.13.6.2729
   PubMedGoogle Scholar
• Lahlou, M. (2013). The success of natural products in drug discovery. Pharmacology & Pharmacy, 4, 17–31.
   Google Scholar
• Li, N., Sood, S., Wang, S., Fang, M., Wang, P., Sun, Z., … Chen, X. (2005). Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib. Clinical Cancer Research, 11, 2089–2096.10.1158/1078-0432.CCR-04-1684
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46, 3–26.10.1016/S0169-409X(00)00129-0
   PubMed Web of Science ®Google Scholar
• Mangal, M., Sagar, P., Singh, H., Raghava, G. P., & Agarwal, S. M. (2013). NPACT: Naturally occurring plant-based anti-cancer compound-activity-target database. Nucleic Acids Research, 41, D1124–D1129.10.1093/nar/gks1047
   PubMed Web of Science ®Google Scholar
• Oprea, T. I. (2002). Virtual screening in lead discovery: A viewpoint. Molecules, 7, 51–62.10.3390/70100051
   Web of Science ®Google Scholar
• Palm, K., Stenberg, P., Luthman, K., & Artursson, P. (1997). Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharmaceutical Research, 14, 568–571.10.1023/A:1012188625088
   PubMed Web of Science ®Google Scholar
• Ponnan, P., Gupta, S., Chopra, M., Tandon, R., Baghel, A. S., Gupta, G., … Hanumantharao, G. R. (2013). 2D-QSAR, docking studies, and in silico ADMET prediction of polyphenolic acetates as substrates for protein acetyltransferase function of glutamine synthetase of Mycobacterium tuberculosis. ISRN Structural Biology, 2013, 1–12.10.1155/2013/373516
   Google Scholar
• Pronk, S., Pall, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., … Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics, 29, 845–854.10.1093/bioinformatics/btt055
   PubMed Web of Science ®Google Scholar
• Qurishi, Y., Hamid, A., Zargar, M. A., Singh, S. K., & Ajit, K. S. (2010). Potential role of natural molecules in health and disease: Importance of boswellic acid. Journal of Medicinal Plants Research, 4, 2778–2785.
   Google Scholar
• Radmark, O., & Samuelsson, B. (2010). Microsomal prostaglandin E synthase-1 and 5- lipoxygenase: Potential drug targets in cancer. Journal of Internal Medicine, 268, 5–14.
   PubMed Web of Science ®Google Scholar
• Rådmark, O., & Werz, O. (2007). 5-Lipoxygenase: Regulation of expression and enzyme activity. Trends in Biochemical Sciences, 32, 332–341.10.1016/j.tibs.2007.06.002
   PubMed Web of Science ®Google Scholar
• Rao, S. N., Head, M. S., Kulkarni, A., & LaLonde, J. M. (2007). Validation studies of the site-directed docking program LibDock. Journal of Chemical Information and Modeling, 47, 2159–2171.10.1021/ci6004299
   PubMed Web of Science ®Google Scholar
• Romano, M., Catalano, A., Nutini, M., DUrbano, E., Crescenzi, C., Clària, J., … Procopio, A. (2001). 5-Lipoxygenase regulates malignant mesothelial cell survival: Involvement of vascular endothelial growth factor. The FASEB Journal, 15, 2326–2336.10.1096/fj.01-0150com
   PubMed Web of Science ®Google Scholar
• Safarzadeh, E., Shotorbani, S. S., & Baradaran, B. (2014). Herbal medicine as inducers of apoptosis in cancer treatment. Advanced Pharmaceutical Bulletin, 4, 421–427.
   PubMedGoogle Scholar
• Schneider, C., & Pozzi, A. (2011). Cyclooxygenases and lipoxygenases in cancer. Cancer Metastasis Reviews, 30, 277–294.10.1007/s10555-011-9310-3
   PubMed Web of Science ®Google Scholar
• Segall, M. D., Beresford, A. P., Gola, J. M., Hawksley, D., & Tarbit, M. H. (2006). Focus on success: Using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery. Expert Opinion on Drug Metabolism & Toxicology, 2, 325–337.
   PubMed Web of Science ®Google Scholar
• Singla, D., Sharma, A., Kaur, J., Panwar, B., & Raghava, G. P. S. (2010). BIAdb: A curated database of benzylisoquinolinealkaloids. BMC Pharmacology, 10, 2210–2214.
   Google Scholar
• Tavakoli, J., Miar, S., Zadehzare, M. M., & Akbari, H. (2012). Evaluation of effectiveness of herbal medication in cancer care: A review study. Iranian Journal of Cancer Prevention, 5, 144–156.
   PubMedGoogle Scholar
• Wang, C. Z., Calway, T., & Yuan, C. S. (2012). Herbal medicines as adjuvants for cancer therapeutics. The American Journal of Chinese Medicine, 40, 657–669.10.1142/S0192415X12500498
   PubMed Web of Science ®Google Scholar
• Werz, O., & Steinhilber, D. (2006). Therapeutic options for 5-lipoxygenase inhibitors. Pharmacology & Therapeutics, 112, 701–718.
   PubMed Web of Science ®Google Scholar
• Xie, C., Kang, J., Li, Z., Schauss, A. G., Badger, T. M., Nagarajan, S., … Wu, X. (2012). The açaí flavonoid velutin is a potent anti-inflammatory agent: Blockade of LPS-mediated TNF-α and IL-6 production through inhibiting NF-κB activation and MAPK pathway. The Journal of Nutritional Biochemistry, 23, 1184–1191.10.1016/j.jnutbio.2011.06.013
   PubMed Web of Science ®Google Scholar
• Zahir, A., Jossang, A., Bodo, B., Provost, J., Cosson, J. P., & Sévenet, T. (1996). DNA topoisomerase I inhibitors: Cytotoxic flavones from Lethedon tannaensis. Journal of Natural Products, 59, 701–703.10.1021/np960336f
   PubMed Web of Science ®Google Scholar